SLB
46
2
GS
69
-3
LMT
52
2
EXC
58
11
CMG
70
-2
CF
44
-3
BIIB
45
-3
AIV
62
-2
OI
39
-4
CAT
69
3
NUE
40
-3
DNB
46
-2
NWL
35
-4
CB
57
3
BLK
69
11
CINF
58
4
DVA
73
2
IFF
69
13
L
63
3
BXP
52
-2
SLB
46
2
GS
69
-3
LMT
52
2
EXC
58
11
CMG
70
-2
CF
44
-3
BIIB
45
-3
AIV
62
-2
OI
39
-4
CAT
69
3
NUE
40
-3
DNB
46
-2
NWL
35
-4
CB
57
3
BLK
69
11
CINF
58
4
DVA
73
2
IFF
69
13
L
63
3
BXP
52
-2
Financhill
Back

Soleno Therapeutics 10K Form

Buy
65

SLNO
Soleno Therapeutics

Last Price:
46.90
Seasonality Move:
-10.12%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SLNO News And Ratings

See the #1 stock for the next 7 days that we like better than SLNO

SLNO Financial Statistics

Sales & Book Value

Annual Sales: $387.56K
Cash Flow: $-12.54M
Price / Cash Flow: 0
Annual Sales: $4.30
Price / Book: 11.87

Profitability

EPS (TTM): -2.70660
Net Income (TTM): $-52.03M
Gross Margin: $34.87K
Return on Equity: 0%
Return on Assets: 0%

Soleno Therapeutics Earnings Forecast

Key Soleno Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 2 years for SLNO is 9.00%.
  • The Selling, General & Administrative Expenses for SLNO have been equal to 2,032.79% of Gross Profit Margin.
  • The Interest Expense is -3.83% of Operating Income.
  • Per Share Earnings over the last 12 years have been positive in 9 years.

Soleno Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: SLNO
CUSIP: 834203
Website: soleno.life

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SLNO Technical Analysis vs Fundamental Analysis

Buy
65
Soleno Therapeutics (SLNO) is a Buy

Is Soleno Therapeutics a Buy or a Sell?